Insider Selling: Cardlytics (NASDAQ:CDLX) CFO Sells $19,279.11 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 8,493 shares of the business’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $2.27, for a total transaction of $19,279.11. Following the completion of the sale, the chief financial officer directly owned 195,417 shares of the company’s stock, valued at $443,596.59. The trade was a 4.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Cardlytics Price Performance

CDLX opened at $2.37 on Friday. The company has a 50-day moving average of $1.57 and a 200-day moving average of $1.73. The company has a market capitalization of $126.18 million, a P/E ratio of -0.65 and a beta of 1.45. Cardlytics, Inc. has a 1-year low of $0.85 and a 1-year high of $5.24. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.16 and a current ratio of 1.16.

Analyst Upgrades and Downgrades

CDLX has been the subject of several research reports. Evercore ISI decreased their price target on shares of Cardlytics from $3.00 to $2.00 and set an “in-line” rating for the company in a report on Friday, August 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $2.25.

Institutional Investors Weigh In On Cardlytics

Hedge funds have recently made changes to their positions in the company. Millennium Management LLC purchased a new stake in shares of Cardlytics in the 4th quarter valued at approximately $535,000. Lane Generational LLC purchased a new stake in shares of Cardlytics in the 1st quarter valued at approximately $1,109,000. Deutsche Bank AG lifted its position in shares of Cardlytics by 123.8% in the 1st quarter. Deutsche Bank AG now owns 48,728 shares of the company’s stock valued at $89,000 after acquiring an additional 26,958 shares in the last quarter. Two Sigma Investments LP lifted its position in shares of Cardlytics by 12.5% in the 4th quarter. Two Sigma Investments LP now owns 94,901 shares of the company’s stock valued at $352,000 after acquiring an additional 10,508 shares in the last quarter. Finally, ProShare Advisors LLC purchased a new stake in shares of Cardlytics in the 4th quarter valued at approximately $43,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.